Evaluation of Drug Display in Critical Care Setting

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-07-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using sEMG of the Diaphragm to Assess Readiness for Extubation

NCT07110129

Critical Illness

RECRUITING

Clinical Impact of Non-invasive Hemodynamic Monitoring

NCT02950597

Heart Failure

COMPLETED

Physiologic Signals and Signatures With the Accuryn™ Monitoring System in Intensive Care Patients

NCT02602782

Critical Care, Intensive Care

COMPLETED

Detecting Post-surgical Respiratory Compromise and Prompting Patients to Self-rescue: An Early Feasibility Study

NCT02962557

Anesthesia

ACTIVE_NOT_RECRUITING NA

Effects of Remote Patient Monitoring on Heart Failure Management

NCT00778986

Heart Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study has two objectives: First, before the medication monitor is shown to anesthesiologists in a clinical setting, the PKPD models must be validated to assess the clinical reliability of the model-based predictions for patients undergoing general anesthesia. Second, once the PKPD models have been successfully validated, presenting it to anesthesiologists during administration of anesthesia will assess the impact of the graphical medication monitor. Differences in performance and patient care will be determined by comparing anesthesiologists who are presented with the monitor to those who care for patients without the monitor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Decision Making

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

For the phase of the study in which the utility of the graphical medication monitor is assessed, the monitor will not be shown to anesthesiologists placed in the control condition.

No interventions assigned to this group

2

In the experimental condition, anesthesiologists will be shown the medication monitor to aid their expertise and decision-making.

medication monitor

Intervention Type DEVICE

the medication monitor will aid in expertise and decision-making.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

medication monitor

the medication monitor will aid in expertise and decision-making.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents and have been trained on the graphic display

Exclusion Criteria

* Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents that have not been trained on the graphic display

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes